p53 can inhibit cell proliferation through caspase-mediated cleavage of ERK2/MAPK

Cell Death and Differentiation

Volumn 11, Issue 6, 2004, Pages 596-607

  Marchetti, A ^a,d   Cecchinelli, B ^a   D'Angelo, M ^a   D'Orazi, G ^a,b   Crescenzi, M ^c   Sacchi, A ^a   Soddu, S ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Caspases; Growth arrest; p53 target; Protein degradation; Signal transduction

Indexed keywords

CASPASE; CASPASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; MUTANT PROTEIN; PROTEIN P21; PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL AGING; CELL CYCLE; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION; CONTROLLED STUDY; DNA DAMAGE; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GROWTH INHIBITION; HALF LIFE TIME; MITOSIS INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CASPASE 3; CASPASES; CELL DIVISION; CELL LINE, TRANSFORMED; DNA DAMAGE; DOWN-REGULATION; DOXORUBICIN; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; TUMOR SUPPRESSOR PROTEIN P53;

EID: 2942724090     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401368     Document Type: Article

References (43)

1. Lewis TS, Shapiro PS and Ahn NG (1998) Signal transduction through MAP kinase cascades. Adv. Cancer Res. 74: 49-139
2. Marshall CJ (1995) Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80: 179-185
3. Cowley S, Paterson H, Kemp P and Marshall CJ (1994) Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77: 841-852
4. Lin AW, Barradas M, Stone JC, van Aelst L, Serrano M and Lowe SW (1998) Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev. 12: 3008-3019
5. ARF. Cell 103: 321-330
6. Serrano M, Lin AW, McCurrach ME, Beach D and Lowe SW (1997) Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88: 593-602
7. Lowe SW (1999) Activation of p53 by oncogenes. Endocr. Relat. Cancer 6: 45-48
8. Lee SW, Fang L, Igarashi M, Ouchi T, Lu KP and Aaronson SA (2000) Sustained activation of Ras/Raf/mitogen-activated protein kinase cascade by the tumor suppressor p53. Proc. Natl. Acad. Sci. USA 97: 8302-8305
9. Deguin-Chambon V, Vacher M, Jullien M, May E and Bourdon J-C (2000) Direct transactivation of c-Ha-ras gene by p53: evidence for its involvement in p53 transactivation activity and p53-mediated apoptosis. Oncogene 19: 5831-5841
10. Peeper DS, Upton TM, Ladha MH, Neuman E, Zalvide J, Bernards R, DeCaprio JA and Ewen ME (1997) Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein. Nature 386: 177-181
11. ARF links the tumour suppressors RB and p53. Nature 395: 124-125
12. Sherr CJ and Weber JD (2000) The ARF/p53 pathway. Curr. Opin. Genet. Dev. 10: 94-99
13. Pearson M, Carbone R, Sebastiani C, Cioce M, Fagioli M, Saito S, Higashimoto Y, Appella E, Minucci S, Pandolfi PP and Pelicci PG (2000) PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature 406: 207-210
14. Wang X, Martindale JL and Holbrook NJ (2000) Requirement for ERK activation in cisplatin-induced apoptosis. J. Biol. Chem. 275: 39435-39443
15. Manni I, Mazzaro G, Gurtner A, Mantovani R, Haugwitz U, Krause K, Engeland K, Sacchi A, Soddu S and Piaggio G (2001) NF-Y mediates the transcriptional inhibition of the cyclin B1, cyclin B2, and cdc25C promoters upon induced G2 arrest. J. Biol. Chem. 276: 5570-5576
16. Fukuda M, Asano S, Nakamura T, Adachi M, Yoshida M, Yanagida M and Nishida E (1997) CRM1 is responsible for intracellular transport mediated by the nuclear export signal. Nature 390: 308-311
17. Freedman DA and Levine AJ (1998) Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6. Mol. Cell. Biol. 18: 7288-7293
18. Smart P, Lane EB, Lane DP, Midgley C, Vojtesek B and Laín S (1999) Effects on normal fibroblasts and neuroblastoma cells of the activation of the p53 response by the nuclear export inhibitor leptomycin B. Oncogene 18: 7378-7386
19. Innocente SA, Abrahamson JL, Cogswell JP and Lee JM (1999) p53 regulates a G2 checkpoint through cyclin B1. Proc. Natl. Acad. Sci. USA 96: 2147-2152
20. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825
21. Gottlieb E and Oren M (1998) p53 facilitates pRb cleavage in IL-3-deprived cells: novel pro-apoptotic activity of p53. EMBO J. 17: 3587-3596
22. Bachelder RE, Ribick MJ, Marchetti A, Falcioni R, Soddu S, Davis KR and Mercurio AM (1999) p53 inhibits ↑β4 integrin signaling by promoting the caspase 3-dependent cleavage of AKT/PKB. J. Cell Biol. 147: 1063-1072
23. De Maria R, Zeuner A, Eramo A, Domenichelli C, Bonc, D, Grignani F, Srinivasula SM, Alnemri ES, Testa U and Peschle C (1999) Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1. Nature 401: 489-493
24. Cohen GM (1997) Caspases: the executioners of apoptosis. Biochem. J. 326: 1-16
25. Brummelkamp TR, Bernards R and Agami R (2002) A system for stable expression of short interfering RNAs in mammalian cells. Science 296: 550-553
26. Ko LJ and Prives C (1996) p53: puzzle and paradigm. Genes Dev. 10: 1054-1072
27. Vousden KH (2000) p53: death star. Cell 103: 691-694
28. Dasika GK, Lin SC, Zhao S, Sung P, Tomkinson A and Lee EY (1999) DNA-damage-induced cell cycle checkpoints and DNA strand break repair in development and tumorigenesis. Oncogene 18: 7883-7899
29. Wrigth JH, Munar E, Jameson DR, Andreassen PR, Margolis RL, Seger R and Krebs EG (1999) Mitogen-activated protein kinase activity is required for the G2/M transition of the cell cycle in mammalian fibroblasts. Proc. Natl. Acad. Sci. USA 96: 11335-11340
30. Hitomi M and Stacey DW (2001) Ras-dependent cell cycle commitment during G2 phase. FEBS Lett. 490: 123-131
31. D'Orazi G, Soddu S and Sacchi A (2000) Activation of p53/p21waf1 pathway is associated with senescence during v-Ha-ras transformation of immortal C2C12 myoblasts. Anticancer Res. 20: 3497-3502
32. Widmann C, Gibson S and Johnson GL (1998) Caspase-dependent cleavage of signaling proteins during apoptosis. J. Biol. Chem. 273: 7141-7147
33. Pochampally R, Fodera B, Chen L, Shao W, Levine EA and Chen J (1998) A 60 kD MDM2 isoform is produced by caspase cleavage in non-apoptotic tumor cells. Oncogene 17: 2629-2636
34. Gentiletti F, Mancini F, D'Angelo M, Sacchi A, Pontecorvi A, Jochemsen AG and Moretti F (2002) MDMX stability is regulated by p53-induced caspase cleavage in NIH-3T3 mouse fibroblasts. Oncogene 21: 867-877
35. Fang L, Li G, Liu G, Lee SW and Aaronson SA (2001) p53 induction of heparin-binding EGF-like growth factor counteracts p53 growth suppression through activation of MAPK and PI3K/Akt signaling cascades. EMBO J. 20: 1931-1939
36. Sabbatini P and McCormick F (1999) Phosphoinositide 3-OH kinase (PI3K) and PKB/Akt delay the onset of p53-mediated, transcriptionally dependent apoptosis. J. Biol. Chem. 274: 24263-24269
37. Kinzler KW and Vogelstein B (1996) Lessons from hereditary colorectal cancer. Cell 87: 159-170
38. D'Orazi G, Marchetti A, Crescenzi M, Coen S, Sacchi A and Soddu S (2000) Exogenous wt-p53 protein is active in transformed cells but not in their non-transformed counterparts: implications for cancer gene therapy without tumor targeting. J. Gene Med. 2: 11-21
39. Del Bufalo D, Cucco C, Leonetti C, Citro G, Dagnano I, Benassi M, Geiser T, Zon G, Calabretta B and Zupi G (1996) Effect of cisplatin and c-myb antisense phosphorothioate oligodeoxynucleotides combination on a human colon carcinoma cell line in vitro and in vivo. Br. J. Cancer 74: 387-393
40. Graham F and Prevec L (1991) Manipulation of adenovirus. In Methods of Molecular Biology, Murray EJ, ed (Clifton, NJ: Humana Press) Vol. 7, pp. 109-128
41. Agami R, Blandino G, Oren M and Shaul Y (1999) Interaction of c-Abl and p73alpha and their collaboration to induce apoptosis. Nature 399: 809-813
42. Morgenstern JP and Land H (11990) Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18: 3587-3596
43. Shaulian E, Zauberman A, Ginsberg D and Oren M (1992) Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding. Mol. Cell. Biol. 12: 5581-5592